{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:50:44Z","timestamp":1790329844220,"version":"4.1.0"},"reference-count":115,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T00:00:00Z","timestamp":1519257600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1093\/ndt\/gfy023","type":"journal-article","created":{"date-parts":[[2018,1,20]],"date-time":"2018-01-20T12:08:33Z","timestamp":1516450113000},"page":"1887-1895","source":"Crossref","is-referenced-by-count":21,"title":["Renal injury progression in autosomal dominant polycystic kidney disease: a look beyond the cysts"],"prefix":"10.1093","volume":"33","author":[{"given":"Vasileios","family":"Raptis","sequence":"first","affiliation":[{"name":"Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos","family":"Loutradis","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis A","family":"Sarafidis","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,21]]},"reference":[{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B1","volume-title":"Comprehensive Clinical Nephrology","author":"Torres","year":"2010"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B2","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1097\/01.ASN.0000028643.17901.42","article-title":"Genetics and pathogenesis of polycystic kidney disease","volume":"13","author":"Igarashi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ncpneph0070","article-title":"Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases","volume":"2","author":"Torres","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B4","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","article-title":"Clinical practice: autosomal dominant polycystic kidney disease","volume":"359","author":"Grantham","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: the last 3 years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B6","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1091\/mbc.e07-02-0142","article-title":"Polycystin-1 induces cell migration by regulating phosphatidylinositol 3-kinase-dependent cytoskeletal rearrangements and GSK3beta-dependent cell cell mechanical adhesion","volume":"18","author":"Boca","year":"2007","journal-title":"Mol Biol Cell"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B7","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","article-title":"PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein","volume":"272","author":"Mochizuki","year":"1996","journal-title":"Science"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1681\/ASN.V1211","article-title":"Vascular expression of polycystin-2","volume":"12","author":"Torres","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B9","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/CIRCRESAHA.108.192765","article-title":"Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades","volume":"104","author":"AbouAlaiwi","year":"2009","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000132462","article-title":"Non-random distribution and sensory functions of primary cilia in vascular smooth muscle cells","volume":"31","author":"Lu","year":"2008","journal-title":"Kidney Blood Press Res"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B11","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1681\/ASN.V84616","article-title":"Vascular expression of polycystin","volume":"8","author":"Griffin","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<439::AID-PATH367>3.0.CO;2-P","article-title":"Cellular localization and tissue distribution of polycystin-1","volume":"188","author":"Peters","year":"1999","journal-title":"J Pathol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B13","doi-asserted-by":"crossref","first-page":"12174","DOI":"10.1073\/pnas.211191098","article-title":"Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene","volume":"98","author":"Boulter","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B14","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1073\/pnas.040550097","article-title":"Polycystin 1 is required for the structural integrity of blood vessels","volume":"97","author":"Kim","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B15","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/CIRCULATIONAHA.107.710111","article-title":"Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1","volume":"117","author":"Nauli","year":"2008","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B16","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0002-9440(10)65428-4","article-title":"Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue","volume":"154","author":"Ong","year":"1999","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.ackd.2010.01.001","article-title":"Hypertension in autosomal dominant polycystic kidney disease","volume":"17","author":"Chapman","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1573402111309010007","article-title":"The genetics of vascular complications in autosomal dominant polycystic kidney disease (ADPKD)","volume":"9","author":"Rossetti","year":"2013","journal-title":"Curr Hypertens Rev"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B19","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/CIRCULATIONAHA.113.005746","article-title":"Survivin-induced abnormal ploidy contributes to cystic kidney and aneurysm formation","volume":"129","author":"Aboualaiwi","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B20","doi-asserted-by":"crossref","first-page":"e12821","DOI":"10.1371\/journal.pone.0012821","article-title":"Pkd1 and Pkd2 are required for normal placental development","volume":"5","author":"Garcia-Gonzalez","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/ajkd.2002.33908","article-title":"Recurrent fetal loss associated with bilineal inheritance of type 1 autosomal dominant polycystic kidney disease","volume":"40","author":"Paterson","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/labinvest.2010.159","article-title":"Pkd1-inactivation in vascular smooth muscle cells and adaptation to hypertension","volume":"91","author":"Hassane","year":"2011","journal-title":"Lab Invest"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B23","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B24","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B25","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1681\/ASN.V271219","article-title":"Cyst decompression surgery for autosomal dominant polycystic kidney disease","volume":"2","author":"Elzinga","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/MAJ.0b013e318256754f","article-title":"Efficacy and safety of mTOR inhibitor therapy in patients with early-stage autosomal dominant polycystic kidney disease: a meta-analysis of randomized controlled trials","volume":"344","author":"He","year":"2012","journal-title":"Am J Med Sci"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.transproceed.2013.10.040","article-title":"Sirolimus for treatment of autosomal-dominant polycystic kidney disease: a meta-analysis of randomized controlled trials","volume":"46","author":"Liu","year":"2014","journal-title":"Transplant Proc"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1089\/end.2012.0529","article-title":"Surgical cyst decortication in autosomal dominant polycystic kidney disease","volume":"27","author":"Millar","year":"2013","journal-title":"J Endourol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/jch.12277","article-title":"Renal sympathetic-nerve ablation for uncontrolled hypertension in a patient with single-kidney autosomal dominant polycystic kidney disease","volume":"16","author":"Riccio","year":"2014","journal-title":"J Clin Hypertens"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B30","doi-asserted-by":"crossref","first-page":"H33","DOI":"10.1152\/ajpheart.01102.2011","article-title":"Pkd2 mesenteric vessels exhibit a primary defect in endothelium-dependent vasodilatation restored by rosiglitazone","volume":"304","author":"Brookes","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1590\/S0100-879X2011007500068","article-title":"Molecular and cellular pathogenesis of autosomal dominant polycystic kidney disease","volume":"44","author":"Bastos","year":"2011","journal-title":"Braz J Med Biol Res"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B32","volume-title":"Comprehensive Clinical Nephrology","author":"Sullivian","year":"2007"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B33","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1093\/hmg\/ddh336","article-title":"Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease","volume":"13","author":"Lantinga-van Leeuwen","year":"2004","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B34","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/hmg\/ddn045","article-title":"Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia","volume":"17","author":"Patel","year":"2008","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B35","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1681\/ASN.2014121192","article-title":"The future of polycystic kidney disease research\u2013as seen by the 12 Kaplan awardees","volume":"26","author":"Antignac","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ng0792-235","article-title":"Multilocus polycystic disease","volume":"1","author":"Reeders","year":"1992","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ki.2015.207","article-title":"A polycystin-centric view of cyst formation and disease: the polycystins revisited","volume":"88","author":"Ong","year":"2015","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B38","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/hmg\/ddp147","article-title":"Renal injury is a third hit promoting rapid development of adult polycystic kidney disease","volume":"18","author":"Takakura","year":"2009","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B39","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1093\/hmg\/ddp190","article-title":"Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways","volume":"18","author":"Happe","year":"2009","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B40","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1681\/ASN.2013080864","article-title":"Scattered deletion of PKD1 in kidneys causes a cystic snowball effect and recapitulates polycystic kidney disease","volume":"26","author":"Leonhard","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B41","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1083\/jcb.201006173","article-title":"The cell biology of polycystic kidney disease","volume":"191","author":"Chapin","year":"2010","journal-title":"J Cell Biol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B42","doi-asserted-by":"crossref","first-page":"F1012","DOI":"10.1152\/ajprenal.00181.2003","article-title":"Regulation of calcium signaling by polycystin-2","volume":"286","author":"Cantiello","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2369-14-34","article-title":"Intracellular calcium release modulates polycystin-2 trafficking","volume":"14","author":"Miyakawa","year":"2013","journal-title":"BMC Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B44","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.bbadis.2011.01.011","article-title":"Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease","volume":"1812","author":"Terryn","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ki.2009.438","article-title":"Cyclic nucleotide signaling in polycystic kidney disease","volume":"77","author":"Wang","year":"2010","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrneph.2009.13","article-title":"Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease","volume":"5","author":"Ecder","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B47","doi-asserted-by":"crossref","first-page":"832.e837","DOI":"10.1016\/j.amjmed.2012.12.018","article-title":"Changing referral characteristics of patients with autosomal dominant polycystic kidney disease","volume":"126","author":"Helal","year":"2013","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2215\/CJN.09500911","article-title":"Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease","volume":"7","author":"Chapman","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B49","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2215\/CJN.01581105","article-title":"Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years","volume":"1","author":"Dicks","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B50","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.V8101560","article-title":"Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease","volume":"8","author":"Johnson","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B51","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1681\/ASN.V121194","article-title":"Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects","volume":"12","author":"Ecder","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B52","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/ckj\/sft031","article-title":"Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)","volume":"6","author":"Sans-Atxer","year":"2013","journal-title":"Clin Kidney J"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B53","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2215\/CJN.00910306","article-title":"Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease","volume":"2","author":"Torres","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B55","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2215\/CJN.00330705","article-title":"Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes","volume":"1","author":"Grantham","year":"2005","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B56","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.bbadis.2011.06.012","article-title":"Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD)","volume":"1812","author":"Norman","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B57","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","article-title":"Why kidneys fail in autosomal dominant polycystic kidney disease","volume":"7","author":"Grantham","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B58","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B59","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1681\/ASN.2009121302","article-title":"Sirolimus therapy to halt the progression of ADPKD","volume":"21","author":"Perico","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B60","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B61","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.2011040340","article-title":"Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease","volume":"23","author":"Novalic","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B62","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2215\/CJN.02650313","article-title":"Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study","volume":"9","author":"Braun","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B63","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","article-title":"The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease","volume":"323","author":"Chapman","year":"1990","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B64","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/01.hjh.0000222765.30348.0d","article-title":"The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients","volume":"24","author":"Doulton","year":"2006","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B65","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/ki.1992.413","article-title":"Renal histology in polycystic kidney disease with incipient and advanced renal failure","volume":"42","author":"Zeier","year":"1992","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B66","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ki.1988.115","article-title":"The anatomy of the renin-secreting cell in adult polycystic kidney disease","volume":"33","author":"Graham","year":"1988","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B67","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ki.1992.297","article-title":"Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease","volume":"42","author":"Torres","year":"1992","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B68","doi-asserted-by":"crossref","first-page":"F775","DOI":"10.1152\/ajprenal.00370.2003","article-title":"The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease","volume":"287","author":"Loghman-Adham","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B69","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3317\/jraas.2006.023","article-title":"Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease","volume":"7","author":"Lawson","year":"2006","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B70","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1291\/hypres.27.221","article-title":"Renal vascular resistance and renin-angiotensin system in the pathogenesis of early hypertension in autosomal dominant polycystic kidney disease","volume":"27","author":"Ramunni","year":"2004","journal-title":"Hypertens Res"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B71","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B72","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/ndt\/gfg417","article-title":"No effect of enalapril on progression in autosomal dominant polycystic kidney disease","volume":"18","author":"van Dijk","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B73","first-page":"Cd010294","article-title":"Interventions for preventing the progression of autosomal dominant polycystic kidney disease","author":"Bolignano","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B74","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1093\/ndt\/gft513","article-title":"Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease","volume":"29","author":"Rahbari-Oskoui","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B75","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3181\/0802-RM-54","article-title":"Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease","volume":"233","author":"Gattone","year":"2008","journal-title":"Exp Biol Med (Maywood)"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B76","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1681\/ASN.V12112427","article-title":"Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension","volume":"12","author":"Klein","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B77","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00392-013-0647-1","article-title":"Effect of percutaneous renal denervation on blood pressure level and sympathetic activity in a patient with polycystic kidney disease","volume":"103","author":"Prejbisz","year":"2014","journal-title":"Clin Res Cardiol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B78","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000013382","article-title":"Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives","volume":"18","author":"Cerasola","year":"1998","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B79","doi-asserted-by":"crossref","first-page":"H1577","DOI":"10.1152\/ajpheart.00218.2002","article-title":"Alpha(1)-adrenoceptor stimulation directly induces growth of vascular wall in vivo","volume":"283","author":"Erami","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B80","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/hh2101.098379","article-title":"Trophic effect of norepinephrine on arterial intima-media and adventitia is augmented by injury and mediated by different alpha1-adrenoceptor subtypes","volume":"89","author":"Zhang","year":"2001","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B81","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1681\/ASN.V1181469","article-title":"Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats","volume":"11","author":"Amann","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B82","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1523-1755.2001.00936.x","article-title":"Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers","volume":"60","author":"Amann","year":"2001","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B83","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1600-0463.2004.apm1120606.x","article-title":"The expression and activity of renal nitric oxide synthase and circulating nitric oxide in polycystic kidney disease rats","volume":"112","author":"Wang","year":"2004","journal-title":"APMIS"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B84","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1046\/j.1523-1755.2003.00236.x","article-title":"Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease","volume":"64","author":"Wang","year":"2003","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B85","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000101369","article-title":"Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function","volume":"27","author":"Borresen","year":"2007","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B86","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/ndt\/gfq806","article-title":"Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease","volume":"26","author":"Heffernan","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B87","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/ndt\/gfh242","article-title":"Sympathetic hyperactivity in chronic kidney disease","volume":"19","author":"Blankestijn","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B88","first-page":"R879","article-title":"Inhibition of intrarenal NO stimulates renin secretion through a macula densa-mediated mechanism","volume":"272","author":"Schnackenberg","year":"1997","journal-title":"Am J Physiol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B89","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/abio.1999.4008","article-title":"Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay","volume":"269","author":"Morrow","year":"1999","journal-title":"Anal Biochem"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B90","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0300-483X(03)00129-X","article-title":"The nitric oxide donor, V-PYRRO\/NO, protects against acetaminophen-induced nephrotoxicity in mice","volume":"189","author":"Li","year":"2003","journal-title":"Toxicology"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B91","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1440-1797.2012.01659.x","article-title":"Role of asymmetrical dimethylarginine in the progression of renal disease","volume":"18","author":"Raptis","year":"2013","journal-title":"Nephrology (Carlton)"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B92","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1046\/j.1523-1755.2003.00913.x","article-title":"Endothelial-derived vasoactive mediators in polycystic kidney disease","volume":"63","author":"Al-Nimri","year":"2003","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B93","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0272-6386(00)70265-4","article-title":"Gender-dependent effect of L-NAME on polycystic kidney disease in Han: SPRD rats","volume":"35","author":"Yoshida","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B94","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/path.2769","article-title":"Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-beta1 synthesis","volume":"223","author":"Mihout","year":"2011","journal-title":"J Pathol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B95","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.lfs.2009.03.018","article-title":"Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease (CKD)","volume":"84","author":"Ueda","year":"2009","journal-title":"Life Sci"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B96","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/01.HYP.27.5.1165","article-title":"Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade","volume":"27","author":"Yamada","year":"1996","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B97","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/hmg\/11.3.229","article-title":"Modifier effect of ENOS in autosomal dominant polycystic kidney disease","volume":"11","author":"Persu","year":"2002","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B98","doi-asserted-by":"crossref","first-page":"c101","DOI":"10.1159\/000157623","article-title":"Modifier effect of the Glu298Asp polymorphism of endothelial nitric oxide synthase gene in autosomal-dominant polycystic kidney disease","volume":"110","author":"Stefanakis","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B99","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1093\/ndt\/gfg351","article-title":"Autosomal dominant polycystic kidney disease: modifier genes and endothelial dysfunction","volume":"18","author":"Devuyst","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B100","first-page":"69","article-title":"Role of endothelial nitric oxide synthase VNTR (intron 4 a\/b) polymorphism on the progression of renal disease in autosomal dominant polycystic kidney disease","volume":"3","author":"Elumalai","year":"2014","journal-title":"J Renal Inj Prev"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B101","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/nep.12310","article-title":"Effects of endothelial nitric oxide synthase gene on end stage renal disease progression in autosomal dominant polycystic kidney disease","volume":"19","author":"Xue","year":"2014","journal-title":"Nephrology (Carlton)"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B102","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nephro.2007.02.002","article-title":"The past, presence and future of ADMA in nephrology","volume":"3","author":"Kielstein","year":"2007","journal-title":"Nephrol Ther"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B103","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1681\/ASN.V131170","article-title":"Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease","volume":"13","author":"Kielstein","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B104","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/j.ajkd.2007.09.020","article-title":"Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease","volume":"51","author":"Wang","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000353730","article-title":"Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease","volume":"123","author":"Kocyigit","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B106","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000355756","article-title":"Elevated asymmetric dimethylarginine is associated with oxidant stress aggravation in patients with early stage autosomal dominant polycystic kidney disease","volume":"38","author":"Raptis","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B107","doi-asserted-by":"crossref","first-page":"F1198","DOI":"10.1152\/ajprenal.00327.2014","article-title":"Endothelial dysfunction and oxidative stress in polycystic kidney disease","volume":"307","author":"Klawitter","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B108","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000112413","article-title":"Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease","volume":"28","author":"Karamouzis","year":"2008","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B109","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1164\/ajrccm.156.4.12-tac-0","article-title":"Genetic analysis of a quantitative trait in a mouse model of polycystic kidney disease","volume":"156","author":"Iakoubova","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B110","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1681\/ASN.V134991","article-title":"Oxidant stress and reduced antioxidant enzyme protection in polycystic kidney disease","volume":"13","author":"Maser","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B111","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1681\/ASN.V881283","article-title":"Aggravation of polycystic kidney disease in Han: SPRD rats by buthionine sulfoximine","volume":"8","author":"Torres","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B112","doi-asserted-by":"crossref","first-page":"R913","DOI":"10.1152\/ajpregu.00250.2005","article-title":"Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?","volume":"289","author":"Wilcox","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B113","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1172\/JCI115849","article-title":"Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage","volume":"90","author":"Baylis","year":"1992","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B114","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1083\/jcb.200312133","article-title":"Primary cilia of human endothelial cells disassemble under laminar shear stress","volume":"164","author":"Iomini","year":"2004","journal-title":"J Cell Biol"},{"key":"key\n\t\t\t\t2018110203511867300_gfy023-B115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1749-6632.2010.05634.x","article-title":"Oxidative stress caused by mitochondrial calcium overload","volume":"1201","author":"Peng","year":"2010","journal-title":"Ann N Y Acad Sci"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/33\/11\/1887\/26182633\/gfy023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T23:20:37Z","timestamp":1660346437000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/33\/11\/1887\/4898178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,21]]},"references-count":115,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,2,21]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfy023","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,2,21]]}}}